US 11312787
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
granted A61KA61K2039/505A61K2039/6081
Quick answer
US patent 11312787 (Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis) held by The Regents of the University of California expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/6081, A61K39/001102, A61P